Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Michael Schnallinger"'
Autor:
Stephan Schreieck, Michael Schnallinger, August Zabernigg, Horst Oexle, Günther Gastl, Günther Zangerl, Judith Hager, Christian Waldthaler, Michael Fiegl, Irmgard Verdorfer, Reinhard Stauder
Publikováno v:
Wiener klinische Wochenschrift. 123:269-275
BACKGROUND: The objective was to demonstrate feasibility and therapeutic efficacy of routine clinical use of the bendamustine/rituximab combination in lymphoproliferative diseases. PATIENTS AND METHODS: Data were collected retrospectively from 71 pat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4973f94b23859ff458c4b50e9049ceb6
https://doi.org/10.1007/s00508-011-1558-7
https://doi.org/10.1007/s00508-011-1558-7
Autor:
Michael, Mian, Florian, Augustin, Florian, Kocher, Eberhard, Gunsilius, Wolfgang, Willenbacher, August, Zabernigg, Günther, Zangerl, Horst, Oexle, Stefan, Schreieck, Michael, Schnallinger, Michael, Fiegl
Publikováno v:
Anticancer research. 34(5)
Diffuse large B-cell lymphoma (DLBCL) is a rather aggressive disease and the natural course of this lymphoma is very dismal. However, first the introduction of anthracycline-containing chemotherapy regimens and then the addition of rituximab were imp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::405159338132c870e78d912b9c166ef0
https://pubmed.ncbi.nlm.nih.gov/24778077
https://pubmed.ncbi.nlm.nih.gov/24778077